Poor response to substitution therapy with cortisone acetate in patients with congenital adrenal hyperplasia
{{output}}
Although cortisone acetate is approved worldwide as corticosteroid substitution therapy in congenital adrenal hyperplasia (21-hydroxylase deficiency), its effectiveness is uncertain since its biologic activity depends on activation by 11β-hydroxysteroid dehyd... ...
